Home > Name List By s > Sunitinib

CAS No 557795-19-4 , Sunitinib

  • Name: Sunitinib
  • Synonyms: Sunitinib intermediate; 1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)- (5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4- dimethyl-; N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-indolin-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide;Sunitinib;SUNITINIB-D4; SUNITINIB BASE;N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide;
  • CAS Registry Number:
  • Melting Point: 189-191 ºC
  • Flash Point: 299.8 ºC
  • Boiling Point: 572.1 ºC at 760 mmHg
  • Density: 1.229 g/cm3
  • Flash Point: 299.8 ºC
  • Molecular Weight: 398.47
  • InChI: InChI=1/C22H27FN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)/b17-12-
  • Molecular Formula: C22H27FN4O2
  • Molecular Structure:CAS No:557795-19-4 Sunitinib

Related products

Search by region :

Select to

557795-19-4 Sunitinib

  • China Xilin Chemical Group Co., Ltd null
  • Tel: +86-(0)-15527136576
  • Fax: +86-(27)-83820093
  • Address: 16# Luojiashan, Wuchang District, Wuhan, Hubei 430071, null,nullChina
Contact Supplier

557795-19-4 Sunitinib Malate

  • China Pharmasi Chemicals Co.,Ltd null
  • Fax: +86-21-57819315
  • Address: Room 205, Renlesancun50-29,songjiang,shanghai,China null,nullChina
Contact Supplier

557795-19-4 Sunitinib base

Contact Supplier

557795-19-4 SUNITINIB-D4

  • India VARDA Biotech (P) Ltd. [Manufacturer]
  • Tel: +91-22-6693 5686 / 2673 0141 / 2673 4258
  • Fax: +91-22-6693 5687
  • Address: 110 & 111, Kartik Complex
    New link Road, Andheri-(W)
    Mumbai-400053, INDIA. null,nullIndia
Contact Supplier

557795-19-4 Sunitinib

  • China Facus Pharmaceutical Co., Ltd. [Manufacturers]
  • Tel: +86-(574)-6237-8411
  • Fax: +86-(574)-6237-8410
  • Address: 24Fl, Yuanjing Building, Beilun, Ningbo, Zhejiang 315800, Ningbo,ZhejiangChina
Contact Supplier

557795-19-4 Sunitinib

  • China TaiZhou HiKong Chemical Co., Ltd. null
  • Tel: +86-18967213045,13957694715
  • Fax: +86-(580)-6033180,6034626
  • Address: Taizhou Economic Technical Development Zone, Taizhou, Zhejiang 318000, null,nullChina
Contact Supplier

557795-19-4 SUNITINIB

  • United States LGM Pharma [Manufacturer]
  • Tel: 561-981-9994
  • Fax: 561-892-0580
  • Address: 922 Clint Moore Road
    Boca Raton, FL 33487 null,nullUnited States
Contact Supplier

557795-19-4 Sunitinib

  • United States Tecoland Corporation null
  • Tel: +1-(732)-603-9577
  • Fax: +1-(732)-906-1522
  • Address: 100 Menlo Park Drive, Suite 316, Edison, New Jersey 08837-2428, null,nullUnited States
Contact Supplier

557795-19-4 Sunitinib Malate

Contact Supplier

557795-19-4 Sunitinib

  • Sunitinib
  • India J.INC. [Manufacturer]
  • Tel: +91 79 30071152, 30071190, 30071175, 30071153
  • Fax: +91 79 30071176, 26574630
  • Address: # 95, Rangwala Towers, Law garden, Ellisbridge, Ahmedabad 380006, Gujarat State, India. 380006 AhmedabadINDIA Ahmedabad,nullIndia
Contact Supplier

Select to

2/7
Previous 1 2 3 4 5 6 7 Next
References of Sunitinib
Title: Sunitinib
CAS Registry Number: 557795-19-4
CAS Name: N-[2-(Diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
Synonyms: 5-[5-fluoro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide
Molecular Formula: C22H27FN4O2
Molecular Weight: 398.47
Percent Composition: C 66.31%, H 6.83%, F 4.77%, N 14.06%, O 8.03%
Literature References: Tyrosine kinase inhibitor targeting VEGF-R2, PDGF-Rb, KIT and FLT3. Prepn: P. C. Tang et al., WO 0160814 (2001 to Sugen); eidem, US 6573293 (2003 to Sugen; Pharmacia & Upjohn); and kinase inhibition activity: L. Sun et al., J. Med. Chem. 46, 1116 (2003). Pharmacology: D. B. Mendel et al., Clin. Cancer Res. 9, 327 (2003). Clinical pharmacokinetics and evaluation in acute myeloid leukemia: A.-M. O'Farrell et al., ibid. 5465. LC-MS-MS determn in biological samples: S. Barattè et al., J. Chromatogr. A 1024, 87 (2004). Formulation development: A. Sistla et al., Drug Dev. Ind. Pharm. 30 19 (2004). Review of development and therapeutic potential: K. M. Sakamoto, Curr. Opin. Invest. Drugs 5, 1329-1339 (2004).
Properties: Orange solid. pKa 8.5. Log P (octanol/water): 3.1. Soly at 22° (mg/ml): 2582 in 20mM KCl/HCl buffer (pH 2); 364 in 20 mM phosphate buffer (pH 6).
pKa: pKa 8.5
Log P: Log P (octanol/water): 3.1
 
Derivative Type: Maleate
CAS Registry Number: 341031-54-7
Manufacturers' Codes: SU-11248
Trademarks: Sutent (Pfizer)
Molecular Formula: C22H27FN4O2.C4H6O5
Molecular Weight: 532.56
Percent Composition: C 58.64%, H 6.25%, F 3.57%, N 10.52%, O 21.03%
 
Therap-Cat: Antineoplastic.
Keywords: Antineoplastic; Tyrosine Kinase Inhibitors.